Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12313
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJayachandran, Aparnaen
dc.contributor.authorAnaka, Matthewen
dc.contributor.authorPrithviraj, Prashanthen
dc.contributor.authorHudson, Christopheren
dc.contributor.authorMcKeown, Sonja Jen
dc.contributor.authorLo, Pu-Hanen
dc.contributor.authorVella, Laura Jen
dc.contributor.authorGoding, Colin Ren
dc.contributor.authorCebon, Jonathan Sen
dc.contributor.authorBehren, Andreasen
dc.date.accessioned2015-05-16T01:58:40Z
dc.date.available2015-05-16T01:58:40Z
dc.date.issued2014-07-30en
dc.identifier.citationOncotarget; 5(14): 5782-97en
dc.identifier.govdoc25051363en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/12313en
dc.description.abstractEpithelial-to-mesenchymal transition (EMT), in which epithelial cells loose their polarity and become motile mesenchymal cells, is a determinant of melanoma metastasis. We compared gene expression signatures of mesenchymal-like melanoma cells with those of epithelial-like melanoma cells, and identified Thrombospondin 1 (THBS1) as highly up-regulated in the mesenchymal phenotype. This study investigated whether THBS1, a major physiological activator of transforming growth factor (TGF)-beta, is involved in melanoma EMT-like process. We sought to examine expression patterns in distinct melanoma phenotypes including invasive, de-differentiated, label-retaining and drug resistant populations that are putatively associated with an EMT-like process. Here we show that THBS1 expression and secretion was elevated in melanoma cells exhibiting invasive, drug resistant, label retaining and mesenchymal phenotypes and correlated with reduced expression of genes involved in pigmentation. Elevated THBS1 levels were detected in Vemurafenib resistant melanoma cells and inhibition of THBS1 led to significantly reduced chemoresistance in melanoma cells. Notably, siRNA-mediated silencing of THBS1 and neutralizing antibody to THBS1 reduced invasion in mesenchymal-like melanoma cells, while ectopic THBS1 expression in epithelial-like melanoma cells enhanced invasion. Furthermore, the loss of THBS1 inhibited in vivo motility of melanoma cells within the embryonic chicken neural tube. In addition, we found aberrant THBS1 protein expression in metastatic melanoma tumor biopsies. These results implicate a role for THBS1 in EMT, and hence THBS1 may serve as a novel target for strategies aimed at the treatment of melanoma invasion and drug resistance.en
dc.language.isoenen
dc.titleThrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma.en
dc.typeJournal Articleen
dc.identifier.journaltitleOncotargeten
dc.identifier.affiliationLudwig Institute for Cancer Research, Melbourne-Austin Branch, Cancer Immunobiology Laboratory, Heidelberg, VIC 3084, Australiaen
dc.identifier.affiliationLudwig Institute for Cancer Research, University of Oxford, Oxford, OX3 7DQ, UKen
dc.identifier.affiliationDepartment of Anatomy and Neuroscience, University of Melbourne, Victoria, 3010, Australiaen
dc.identifier.affiliationDepartment of Medicine, University of Melbourne, Victoria, 3010, Australiaen
dc.description.pages5782-97en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/25051363en
dc.type.austinJournal Articleen
local.name.researcherCebon, Jonathan S
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.grantfulltextnone-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

4
checked on Mar 1, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.